Original language | English |
---|---|
Pages (from-to) | 1663-1665 |
Number of pages | 3 |
Journal | JACC: Cardiovascular Imaging |
Volume | 15 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2022 |
Keywords
- leaflet height
- mitral valve
- mitral valve-in-valve procedure
- neo-LVOT
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: JACC: Cardiovascular Imaging, Vol. 15, No. 9, 09.2022, p. 1663-1665.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Multimodality Imaging to Assess Leaflet Height in Mitral Bioprosthetic Valves
T2 - Implications for Mitral Valve-in-Valve Procedure
AU - Akodad, Mariama
AU - Sathananthan, Janarthanan
AU - Tzimas, Georgios
AU - Salcudean, Hannah
AU - Hensey, Mark
AU - Gulsin, Gaurav S.
AU - Meier, David
AU - (Anthony) Chuang, Ming yu
AU - Chatfield, Andrew G.
AU - Landes, Uri
AU - Blanke, Philipp
AU - Sondergaard, Lars
AU - Payne, Geoffrey W.
AU - Lutter, Georg
AU - Puehler, Thomas
AU - Wood, David A.
AU - Webb, John G.
AU - Leipsic, Jonathon A.
AU - Sellers, Stephanie L.
N1 - Funding Information: Funding was received from St Paul's Foundation and the Providence Health Care Research Institute (PHCRI) Early Career Research Initiative. Dr Akodad has received research funding from Medtronic, Biotronik, MUSE Explore, and Federation Française de Cardiologie. Dr Sathananthan has received speaker fees from Edwards Lifesciences and NVT Medical; and has reported consulting for Edwards Lifesciences, Boston Scientific, and Medtronic. Dr Tzimas has reported support from the Fondation Vaudoise de Cardiologie. Dr Gulsin has reported support from a British Heart Foundation Travel Fellowship (FS/TF/21/33008). Dr Blanke has reported consulting for Edwards Lifesciences, Boston Scientific, and Neovasc; and has provided computed tomography core laboratory services for Edwards Lifesciences, Medtronic, Neovasc, Boston Scientific, and Abbott, for which no direct compensation was received. Dr Sondergaard has received consultant fees and/or institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and SMT. Dr Wood has reported consulting for and has received research funding from Edwards Lifesciences and Abbott. Dr Webb has reported consulting for Edwards Lifesciences. Dr Leipsic has reported support from a Canadian Research Chair in Advanced Cardiopulmonary Imaging; has reported consulting for MVRX, HeartFlow, and Circle Cardiovascular Imaging; and has provided computed tomography core laboratory services for Edwards Lifesciences, Medtronic, Neovasc, Boston Scientific, and Abbott, for which no direct compensation is received. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: The authors acknowledge the use of explanted bioprosthetic valves from the Cardiovascular Tissue Registry at the Centre for Heart Lung Innovation at St. Paul's Hospital. Approval for use of explanted valves was obtained from the University of British Columbia Research Ethics Board–Providence Health Care.
PY - 2022/9
Y1 - 2022/9
KW - leaflet height
KW - mitral valve
KW - mitral valve-in-valve procedure
KW - neo-LVOT
UR - http://www.scopus.com/inward/record.url?scp=85134823520&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2022.01.010
DO - 10.1016/j.jcmg.2022.01.010
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36075626
AN - SCOPUS:85134823520
SN - 1936-878X
VL - 15
SP - 1663
EP - 1665
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 9
ER -